<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Selection of a BCR-ABL1 TKI for initial treatment of chronic phase CML</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Selection of a BCR-ABL1 TKI for initial treatment of chronic phase CML</h1>
<div class="graphic"><div class="figure"><div class="ttl">Selection of a BCR-ABL1 TKI for initial treatment of chronic phase CML</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Selection of a TKI must consider the toxicity profile, comorbid illnesses, availability, cost, and patient preference. Refer to related UpToDate topics for details of CML risk scoring, eligibility for TKI discontinuation to achieve TFR, outcomes, and adverse effects of individual BCR-ABL1 TKIs.</div><div class="graphic_footnotes">TKI: tyrosine kinase inhibitor; CP: chronic phase; CML: chronic myeloid leukemia; 2G: second generation; TFR: treatment-free remission.</div><div id="graphicVersion">Graphic 130520 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
